4th Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

orphan drug tax credit

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Patent reform

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

***, no specific bill(s), Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, oncology, CMMI, home infusion, Least Costly alternative, Part B, ASP, insulin access, vaccines, flu, prescription drug access and affordability

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
CHARLOTTE SPEARS IVANCIC Legislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John Boehner
ELIZABETH T MURRAY Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham
EMILY H MURRY Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price
PAMELA SMITH Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA)

Health Issues HCR

PL 114-255 - 21st Century Cures, implementation H.R. 878/S. 204 - Right to Try Act H.R. 1231/S. 456 - RACE for Children Act H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act S. 2852 - Pandemic and All Hazards Preparedness Act S.2315 - Over-the-Counter Drug Safety, Innovation, and Reform Act H.R. 6 - SUPPORT for Patients and Communities Act ***no specific bills, importation, supply chain integrity, 304b, biosimilars, orphan drugs, newborn screening, expanded access, priority review, transparency, drug shortages, IPAB

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 456 (115th), H.R. 2430 (115th), S. 260 (115th), H.R. 878 (115th), H.R. 1231 (115th), S. 2315 (115th), S. 204 (115th), S. 2852 (115th), H.R. 849 (115th), H.R. 6 (115th)

Budget/Appropriations BUD

budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018 H.R. 6157 - HHS appropriations and continuing resolution H.R. 695 - Department of Defense Appropriations Act

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1892 (115th), H.R. 6157 (115th), H.R. 695 (115th), H.R. 1625 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.